Takeda Pharmaceutical (TAK) EBIT Growth (5y) (2022 - 2026)
Takeda Pharmaceutical (TAK) EBIT Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.21 Bn | 39.55 Bn | 2.15 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.80 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.14 Bn | 11.61 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.17 Bn | 10.01 Bn | - |
| 10 | Alkermes | 8.23 Bn | 7.57 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.06% |
| Mar 31, 2026 | -2.02% |
| Dec 31, 2025 | -31.78% |
| Sep 30, 2025 | 44.51% |
| Jun 30, 2025 | -3.89% |
| Mar 31, 2025 | -14.18% |
| Sep 30, 2024 | 36.29% |
| Jun 30, 2024 | 21.07% |
| Mar 31, 2024 | 303.71% |
| Dec 31, 2023 | -9.68% |
| Sep 30, 2023 | -66.46% |
| Jun 30, 2023 | 6.29% |
| Mar 31, 2023 | 30.02% |
| Dec 31, 2022 | 5.96% |